Survival analysis and AML development in patients with de novo myelodysplastic syndromes: comparison of six different prognostic scoring systems

[1]  S. Sohn,et al.  Comparisons of prognostic scoring systems for myelodysplastic syndromes: a Korean multicenter study. , 1999, Leukemia research.

[2]  P. Greenberg.  Risk factors and their relationship to prognosis in myelodysplastic syndromes. , 1998, Leukemia research.

[3]  M. Boogaerts,et al.  Treatment and prognostic factors in myelodysplastic syndromes. , 1996, Bailliere's clinical haematology.

[4]  P. Cole,et al.  Epidemiologic perspectives on myelodysplastic syndromes and leukemia. , 1995, Leukemia research.

[5]  E. Estey,et al.  Abnormalities in the long arm of chromosome 11 (11q) in patients with de novo and secondary acute myelogenous leukemias and myelodysplastic syndromes. , 1994, Leukemia.

[6]  U. Germing,et al.  Risk assessment in primary myelodysplastic syndromes: validation of the Düsseldorf score. , 1994, Leukemia.

[7]  H. Gralnick,et al.  The chronic myeloid leukaemias: guidelines for distinguishing chronic granulocytic, atypical chronic myeloid, and chronic myelomonocytic leukaemia: Proposals by the French ‐ American ‐ British Cooperative Leukaemia Group , 1994, British journal of haematology.

[8]  E. Thiel,et al.  Correlation of cytogenetic findings with clinical features in 18 patients with inv(3)(q21q26) or t(3;3)(q21;q26). , 1994, Leukemia.

[9]  A. Duhamel,et al.  Cytogenetic analysis has strong independent prognostic value in de novo myelodysplastic syndromes and can be incorporated in a new scoring system: a report on 408 cases. , 1993, Leukemia.

[10]  M. Sanz,et al.  Two regression models and a scoring system for predicting survival and planning treatment in myelodysplastic syndromes: a multivariate analysis of prognostic factors in 370 patients. , 1989, Blood.

[11]  D. Machin,et al.  Myelodysplastic syndromes: a scoring system with prognostic significance , 1985, British journal of haematology.

[12]  P. Greenberg.  The smoldering myeloid leukemic states: clinical and biologic features. , 1983, Blood.

[13]  H. Gralnick,et al.  Proposals for the classification of the myelodysplastic syndromes , 1982, British journal of haematology.

[14]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .

[15]  J. Bennett,et al.  Advances in the therapy of the myelodysplastic syndromes. , 1999, Cancer treatment and research.

[16]  P. Greenberg,et al.  Prognostic factors and scoring systems in myelodysplastic syndromes. , 1998, Haematologica.

[17]  E. Estey,et al.  Application of the International Scoring System for myelodysplasia to M.D. Anderson patients. , 1997, Blood.

[18]  U. Germing,et al.  Primary myelodysplastic syndromes: analysis of prognostic factors in 235 patients and proposals for an improved scoring system. , 1992, Leukemia.

[19]  Iscn.  International System for Human Cytogenetic Nomenclature , 1978 .

[20]  David R. Cox,et al.  Regression models and life tables (with discussion , 1972 .